We have located links that may give you full text access.
The use of phosphatidylcholine for correction of lower lid bulging due to prominent fat pads.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.] 2001 April
BACKGROUND: Patients with prominent periorbital fat pads often complain of having a persistent "tired" look and seek treatment from their dermatologist.
OBJECTIVE: A non-surgical treatment of fat pads.
METHODS: Thirty patients were treated for prominent lower eyelid fat pads with phosphatidylcholine injection. Pre- and posttreatment photographs were taken for long-term analysis.
RESULTS: A marked reduction of the lower eyelid fat pads was noted over the 2-year follow-up period. There were no recurrences.
CONCLUSION: The injection of phosphatidylcholine (250 mg/5 ml) into the fat pads is a simple office procedure that may postpone or even substitute for lower eyelid blepharoplasty.
OBJECTIVE: A non-surgical treatment of fat pads.
METHODS: Thirty patients were treated for prominent lower eyelid fat pads with phosphatidylcholine injection. Pre- and posttreatment photographs were taken for long-term analysis.
RESULTS: A marked reduction of the lower eyelid fat pads was noted over the 2-year follow-up period. There were no recurrences.
CONCLUSION: The injection of phosphatidylcholine (250 mg/5 ml) into the fat pads is a simple office procedure that may postpone or even substitute for lower eyelid blepharoplasty.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app